12:00 AM
Aug 27, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Suboxone buprenorphine/naloxone sublingual film regulatory update

Reckitt's Reckitt Benckiser Pharmaceuticals Inc. subsidiary said FDA approved 4 mg/1 mg and 12 mg/3 mg dose formulations of Suboxone buprenorphine/naloxone...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >